Rafal Gulej to Tumor Burden
This is a "connection" page, showing publications Rafal Gulej has written about Tumor Burden.
Connection Strength
0.042
-
Optimized monoclonal antibody treatment against ELTD1 for GBM in a G55 xenograft mouse model. J Cell Mol Med. 2020 01; 24(2):1738-1749.
Score: 0.042
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.